Prevention  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
diabetic  ||| S:14 E:23 ||| JJ
foot  ||| S:23 E:28 ||| NN
Diabetic  ||| S:28 E:37 ||| NNP
foot  ||| S:37 E:42 ||| NN
( ||| S:42 E:43 ||| -LRB-
DF ||| S:43 E:45 ||| NNP
)  ||| S:45 E:47 ||| -RRB-
is  ||| S:47 E:50 ||| VBZ
the  ||| S:50 E:54 ||| DT
most  ||| S:54 E:59 ||| RBS
common  ||| S:59 E:66 ||| JJ
chronic  ||| S:66 E:74 ||| JJ
complication ||| S:74 E:86 ||| NN
,  ||| S:86 E:88 ||| ,
which  ||| S:88 E:94 ||| WDT
depends  ||| S:94 E:102 ||| VBZ
mostly  ||| S:102 E:109 ||| RB
on  ||| S:109 E:112 ||| IN
the  ||| S:112 E:116 ||| DT
duration  ||| S:116 E:125 ||| NN
and  ||| S:125 E:129 ||| CC
successful  ||| S:129 E:140 ||| JJ
treatment  ||| S:140 E:150 ||| NN
of  ||| S:150 E:153 ||| IN
diabetes  ||| S:153 E:162 ||| JJ
mellitus ||| S:162 E:170 ||| NN
.  ||| S:170 E:172 ||| .
Based  ||| S:172 E:178 ||| VBN
on  ||| S:178 E:181 ||| IN
epidemiological  ||| S:181 E:197 ||| JJ
studies ||| S:197 E:204 ||| NNS
,  ||| S:204 E:206 ||| ,
it  ||| S:206 E:209 ||| PRP
is  ||| S:209 E:212 ||| VBZ
estimated  ||| S:212 E:222 ||| VBN
that  ||| S:222 E:227 ||| IN
25 ||| S:227 E:229 ||| CD
%  ||| S:229 E:231 ||| NN
of  ||| S:231 E:234 ||| IN
persons  ||| S:234 E:242 ||| NNS
with  ||| S:242 E:247 ||| IN
diabetes  ||| S:247 E:256 ||| JJ
mellitus  ||| S:256 E:265 ||| NNS
( ||| S:265 E:266 ||| -LRB-
PwDM ||| S:266 E:270 ||| NNP
)  ||| S:270 E:272 ||| -RRB-
will  ||| S:272 E:277 ||| MD
develop  ||| S:277 E:285 ||| VB
the  ||| S:285 E:289 ||| DT
problems  ||| S:289 E:298 ||| NNS
with  ||| S:298 E:303 ||| IN
DF  ||| S:303 E:306 ||| NNP
during  ||| S:306 E:313 ||| IN
lifetime ||| S:313 E:321 ||| NN
,  ||| S:321 E:323 ||| ,
while  ||| S:323 E:329 ||| IN
5 ||| S:329 E:330 ||| CD
%  ||| S:330 E:332 ||| NN
do  ||| S:332 E:335 ||| VBP
15 ||| S:335 E:337 ||| CD
%  ||| S:337 E:339 ||| NN
will  ||| S:339 E:344 ||| MD
be  ||| S:344 E:347 ||| VB
treated  ||| S:347 E:355 ||| VBN
for  ||| S:355 E:359 ||| IN
foot  ||| S:359 E:364 ||| NN
or  ||| S:364 E:367 ||| CC
leg  ||| S:367 E:371 ||| NN
amputation ||| S:371 E:381 ||| NN
.  ||| S:381 E:383 ||| .
The  ||| S:383 E:387 ||| DT
treatment  ||| S:387 E:397 ||| NN
is  ||| S:397 E:400 ||| VBZ
prolonged  ||| S:400 E:410 ||| VBN
and  ||| S:410 E:414 ||| CC
expensive ||| S:414 E:423 ||| JJ
,  ||| S:423 E:425 ||| ,
while  ||| S:425 E:431 ||| IN
the  ||| S:431 E:435 ||| DT
results  ||| S:435 E:443 ||| NNS
are  ||| S:443 E:447 ||| VBP
uncertain ||| S:447 E:456 ||| JJ
.  ||| S:456 E:458 ||| .
The  ||| S:458 E:462 ||| DT
changes  ||| S:462 E:470 ||| NNS
in  ||| S:470 E:473 ||| IN
DF  ||| S:473 E:476 ||| NNP
are  ||| S:476 E:480 ||| VBP
influenced  ||| S:480 E:491 ||| VBN
by  ||| S:491 E:494 ||| IN
different  ||| S:494 E:504 ||| JJ
factors  ||| S:504 E:512 ||| NNS
usually  ||| S:512 E:520 ||| RB
connected  ||| S:520 E:530 ||| VBN
with  ||| S:530 E:535 ||| IN
the  ||| S:535 E:539 ||| DT
duration  ||| S:539 E:548 ||| NN
and  ||| S:548 E:552 ||| CC
regulation  ||| S:552 E:563 ||| NN
of  ||| S:563 E:566 ||| IN
diabetes  ||| S:566 E:575 ||| JJ
mellitus ||| S:575 E:583 ||| NN
.  ||| S:583 E:585 ||| .
The  ||| S:585 E:589 ||| DT
first  ||| S:589 E:595 ||| JJ
problems  ||| S:595 E:604 ||| NNS
with  ||| S:604 E:609 ||| IN
DF  ||| S:609 E:612 ||| NNP
are  ||| S:612 E:616 ||| VBP
the  ||| S:616 E:620 ||| DT
result  ||| S:620 E:627 ||| NN
of  ||| S:627 E:630 ||| IN
misbalance  ||| S:630 E:641 ||| NN
between  ||| S:641 E:649 ||| IN
nutritional ||| S:649 E:660 ||| NN
,  ||| S:660 E:662 ||| ,
defensive  ||| S:662 E:672 ||| JJ
and  ||| S:672 E:676 ||| CC
reparatory  ||| S:676 E:687 ||| JJ
mechanisms  ||| S:687 E:698 ||| NNS
on  ||| S:698 E:701 ||| IN
the  ||| S:701 E:705 ||| DT
one  ||| S:705 E:709 ||| CD
hand  ||| S:709 E:714 ||| NN
and  ||| S:714 E:718 ||| CC
the  ||| S:718 E:722 ||| DT
intensity  ||| S:722 E:732 ||| NN
of  ||| S:732 E:735 ||| IN
damaging  ||| S:735 E:744 ||| JJ
factors  ||| S:744 E:752 ||| NNS
against  ||| S:752 E:760 ||| IN
DF  ||| S:760 E:763 ||| NNP
on  ||| S:763 E:766 ||| IN
the  ||| S:766 E:770 ||| DT
other  ||| S:770 E:776 ||| JJ
hand ||| S:776 E:780 ||| NN
.  ||| S:780 E:782 ||| .
Diabetes  ||| S:782 E:791 ||| JJ
mellitus  ||| S:791 E:800 ||| NN
is  ||| S:800 E:803 ||| VBZ
a  ||| S:803 E:805 ||| DT
state  ||| S:805 E:811 ||| NN
of  ||| S:811 E:814 ||| IN
chronic  ||| S:814 E:822 ||| JJ
hyperglycemia ||| S:822 E:835 ||| NN
,  ||| S:835 E:837 ||| ,
consisting  ||| S:837 E:848 ||| VBG
of  ||| S:848 E:851 ||| IN
changes  ||| S:851 E:859 ||| NNS
in  ||| S:859 E:862 ||| IN
carbohydrate ||| S:862 E:874 ||| NN
,  ||| S:874 E:876 ||| ,
protein  ||| S:876 E:884 ||| NN
and  ||| S:884 E:888 ||| CC
fat  ||| S:888 E:892 ||| JJ
metabolism ||| S:892 E:902 ||| NN
.  ||| S:902 E:904 ||| .
As  ||| S:904 E:907 ||| IN
a  ||| S:907 E:909 ||| DT
consequence  ||| S:909 E:921 ||| NN
of  ||| S:921 E:924 ||| IN
the  ||| S:924 E:928 ||| DT
long  ||| S:928 E:933 ||| JJ
duration  ||| S:933 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
diabetes  ||| S:945 E:954 ||| JJ
mellitus ||| S:954 E:962 ||| NN
,  ||| S:962 E:964 ||| ,
late  ||| S:964 E:969 ||| JJ
complications  ||| S:969 E:983 ||| NNS
can  ||| S:983 E:987 ||| MD
develop ||| S:987 E:994 ||| VB
.  ||| S:994 E:996 ||| .
Foot  ||| S:996 E:1001 ||| NNP
is  ||| S:1001 E:1004 ||| VBZ
in  ||| S:1004 E:1007 ||| IN
its  ||| S:1007 E:1011 ||| PRP$
structure  ||| S:1011 E:1021 ||| NN
very  ||| S:1021 E:1026 ||| RB
complex ||| S:1026 E:1033 ||| JJ
,  ||| S:1033 E:1035 ||| ,
combined  ||| S:1035 E:1044 ||| VBN
with  ||| S:1044 E:1049 ||| IN
many  ||| S:1049 E:1054 ||| JJ
large  ||| S:1054 E:1060 ||| JJ
and  ||| S:1060 E:1064 ||| CC
small  ||| S:1064 E:1070 ||| JJ
bones  ||| S:1070 E:1076 ||| NNS
connected  ||| S:1076 E:1086 ||| VBN
with  ||| S:1086 E:1091 ||| IN
ligaments ||| S:1091 E:1100 ||| NN
,  ||| S:1100 E:1102 ||| ,
directed  ||| S:1102 E:1111 ||| VBN
by  ||| S:1111 E:1114 ||| IN
many  ||| S:1114 E:1119 ||| JJ
small  ||| S:1119 E:1125 ||| JJ
and  ||| S:1125 E:1129 ||| CC
large  ||| S:1129 E:1135 ||| JJ
muscles ||| S:1135 E:1142 ||| NNS
,  ||| S:1142 E:1144 ||| ,
interconnected  ||| S:1144 E:1159 ||| VBN
with  ||| S:1159 E:1164 ||| IN
many  ||| S:1164 E:1169 ||| JJ
small  ||| S:1169 E:1175 ||| JJ
and  ||| S:1175 E:1179 ||| CC
large  ||| S:1179 E:1185 ||| JJ
blood  ||| S:1185 E:1191 ||| NN
vessels  ||| S:1191 E:1199 ||| NNS
and  ||| S:1199 E:1203 ||| CC
nerves ||| S:1203 E:1209 ||| NNS
.  ||| S:1209 E:1211 ||| .
Every  ||| S:1211 E:1217 ||| DT
of  ||| S:1217 E:1220 ||| IN
these  ||| S:1220 E:1226 ||| DT
structures  ||| S:1226 E:1237 ||| NNS
can  ||| S:1237 E:1241 ||| MD
be  ||| S:1241 E:1244 ||| VB
changed  ||| S:1244 E:1252 ||| VBN
by  ||| S:1252 E:1255 ||| IN
nutritional ||| S:1255 E:1266 ||| NN
,  ||| S:1266 E:1268 ||| ,
defensive  ||| S:1268 E:1278 ||| JJ
and  ||| S:1278 E:1282 ||| CC
reparatory  ||| S:1282 E:1293 ||| JJ
mechanisms  ||| S:1293 E:1304 ||| NNS
with  ||| S:1304 E:1309 ||| IN
consequential  ||| S:1309 E:1323 ||| JJ
DE  ||| S:1323 E:1326 ||| NNP
Primary  ||| S:1326 E:1334 ||| NNP
prevention  ||| S:1334 E:1345 ||| NN
of  ||| S:1345 E:1348 ||| IN
DF  ||| S:1348 E:1351 ||| NNP
includes  ||| S:1351 E:1360 ||| VBZ
all  ||| S:1360 E:1364 ||| DT
measures  ||| S:1364 E:1373 ||| NNS
involved  ||| S:1373 E:1382 ||| VBN
in  ||| S:1382 E:1385 ||| IN
appropriate  ||| S:1385 E:1397 ||| JJ
maintenance  ||| S:1397 E:1409 ||| NN
of  ||| S:1409 E:1412 ||| IN
nutrition ||| S:1412 E:1421 ||| NN
,  ||| S:1421 E:1423 ||| ,
defense  ||| S:1423 E:1431 ||| NN
and  ||| S:1431 E:1435 ||| CC
reparatory  ||| S:1435 E:1446 ||| CD
mechanisms.First ||| S:1446 E:1462 ||| CD
,  ||| S:1462 E:1464 ||| ,
it  ||| S:1464 E:1467 ||| PRP
is  ||| S:1467 E:1470 ||| VBZ
necessary  ||| S:1470 E:1480 ||| JJ
to  ||| S:1480 E:1483 ||| TO
identify  ||| S:1483 E:1492 ||| VB
the  ||| S:1492 E:1496 ||| DT
high-risk  ||| S:1496 E:1506 ||| JJ
population  ||| S:1506 E:1517 ||| NN
for  ||| S:1517 E:1521 ||| IN
DF ||| S:1521 E:1523 ||| NNP
,  ||| S:1523 E:1525 ||| ,
in  ||| S:1525 E:1528 ||| IN
particular  ||| S:1528 E:1539 ||| JJ
for  ||| S:1539 E:1543 ||| IN
macrovascular ||| S:1543 E:1556 ||| NN
,  ||| S:1556 E:1558 ||| ,
microvascular  ||| S:1558 E:1572 ||| NN
and  ||| S:1572 E:1576 ||| CC
neural  ||| S:1576 E:1583 ||| JJ
complications ||| S:1583 E:1596 ||| NNS
.  ||| S:1596 E:1598 ||| .
The  ||| S:1598 E:1602 ||| DT
high-risk  ||| S:1602 E:1612 ||| JJ
population  ||| S:1612 E:1623 ||| NN
of  ||| S:1623 E:1626 ||| IN
PwDM  ||| S:1626 E:1631 ||| NNP
should  ||| S:1631 E:1638 ||| MD
be  ||| S:1638 E:1641 ||| VB
identified  ||| S:1641 E:1652 ||| VBN
during  ||| S:1652 E:1659 ||| IN
regular  ||| S:1659 E:1667 ||| JJ
examination  ||| S:1667 E:1679 ||| NN
and  ||| S:1679 E:1683 ||| CC
appropriate  ||| S:1683 E:1695 ||| JJ
education  ||| S:1695 E:1705 ||| NN
should  ||| S:1705 E:1712 ||| MD
be  ||| S:1712 E:1715 ||| VB
performed ||| S:1715 E:1724 ||| VBN
.  ||| S:1724 E:1726 ||| .
In  ||| S:1726 E:1729 ||| IN
this  ||| S:1729 E:1734 ||| DT
group ||| S:1734 E:1739 ||| NN
,  ||| S:1739 E:1741 ||| ,
it  ||| S:1741 E:1744 ||| PRP
is  ||| S:1744 E:1747 ||| VBZ
necessary  ||| S:1747 E:1757 ||| JJ
to  ||| S:1757 E:1760 ||| TO
include  ||| S:1760 E:1768 ||| VB
more  ||| S:1768 E:1773 ||| RBR
frequent  ||| S:1773 E:1782 ||| JJ
and  ||| S:1782 E:1786 ||| CC
intensified  ||| S:1786 E:1798 ||| JJ
empowerment  ||| S:1798 E:1810 ||| NN
for  ||| S:1810 E:1814 ||| IN
lifestyle  ||| S:1814 E:1824 ||| JJ
changes ||| S:1824 E:1831 ||| NNS
,  ||| S:1831 E:1833 ||| ,
appropriate  ||| S:1833 E:1845 ||| JJ
diet ||| S:1845 E:1849 ||| NN
,  ||| S:1849 E:1851 ||| ,
regular  ||| S:1851 E:1859 ||| JJ
exercise  ||| S:1859 E:1868 ||| NN
( ||| S:1868 E:1869 ||| -LRB-
including  ||| S:1869 E:1879 ||| VBG
frequent  ||| S:1879 E:1888 ||| JJ
breaks  ||| S:1888 E:1895 ||| NNS
for  ||| S:1895 E:1899 ||| IN
short  ||| S:1899 E:1905 ||| JJ
exercise  ||| S:1905 E:1914 ||| NN
during  ||| S:1914 E:1921 ||| IN
sedentary  ||| S:1921 E:1931 ||| JJ
work ||| S:1931 E:1935 ||| NN
) ||| S:1935 E:1936 ||| -RRB-
,  ||| S:1936 E:1938 ||| ,
regular  ||| S:1938 E:1946 ||| JJ
self  ||| S:1946 E:1951 ||| NN
control  ||| S:1951 E:1959 ||| NN
of  ||| S:1959 E:1962 ||| IN
body  ||| S:1962 E:1967 ||| NN
weight ||| S:1967 E:1973 ||| NN
,  ||| S:1973 E:1975 ||| ,
quit  ||| S:1975 E:1980 ||| VBD
smoking ||| S:1980 E:1987 ||| NN
,  ||| S:1987 E:1989 ||| ,
and  ||| S:1989 E:1993 ||| CC
appropriate  ||| S:1993 E:2005 ||| JJ
treatment  ||| S:2005 E:2015 ||| NN
of  ||| S:2015 E:2018 ||| IN
glycemia ||| S:2018 E:2026 ||| NN
,  ||| S:2026 E:2028 ||| ,
lipid  ||| S:2028 E:2034 ||| JJ
disorders  ||| S:2034 E:2044 ||| NNS
( ||| S:2044 E:2045 ||| -LRB-
treatment  ||| S:2045 E:2055 ||| NN
with  ||| S:2055 E:2060 ||| IN
fenofibrate  ||| S:2060 E:2072 ||| NN
reduces  ||| S:2072 E:2080 ||| VBZ
the  ||| S:2080 E:2084 ||| DT
incidence  ||| S:2084 E:2094 ||| NN
of  ||| S:2094 E:2097 ||| IN
DF  ||| S:2097 E:2100 ||| NNP
amputations  ||| S:2100 E:2112 ||| NNS
( ||| S:2112 E:2113 ||| -LRB-
EBM-Ib ||| S:2113 E:2119 ||| NNP
/ ||| S:2119 E:2120 ||| NNP
A ||| S:2120 E:2121 ||| NNP
) ||| S:2121 E:2122 ||| -RRB-
,  ||| S:2122 E:2124 ||| ,
hypertension ||| S:2124 E:2136 ||| NN
,  ||| S:2136 E:2138 ||| ,
hyperuricemia ||| S:2138 E:2151 ||| NN
,  ||| S:2151 E:2153 ||| ,
neuropathy ||| S:2153 E:2163 ||| NN
,  ||| S:2163 E:2165 ||| ,
and  ||| S:2165 E:2169 ||| CC
angiopathy  ||| S:2169 E:2180 ||| NNS
( ||| S:2180 E:2181 ||| -LRB-
surgical  ||| S:2181 E:2190 ||| FW
reconstructive  ||| S:2190 E:2205 ||| FW
bypass ||| S:2205 E:2211 ||| FW
)  ||| S:2211 E:2213 ||| -RRB-
or  ||| S:2213 E:2216 ||| CC
endovascular  ||| S:2216 E:2229 ||| NNS
( ||| S:2229 E:2230 ||| -LRB-
percutaneous  ||| S:2230 E:2243 ||| FW
transluminar  ||| S:2243 E:2256 ||| FW
angioplasty ||| S:2256 E:2267 ||| FW
) ||| S:2267 E:2268 ||| -RRB-
.  ||| S:2268 E:2270 ||| .
In  ||| S:2270 E:2273 ||| IN
the  ||| S:2273 E:2277 ||| DT
low-risk  ||| S:2277 E:2286 ||| JJ
group  ||| S:2286 E:2292 ||| NN
of  ||| S:2292 E:2295 ||| IN
PwDM ||| S:2295 E:2299 ||| NNP
,  ||| S:2299 E:2301 ||| ,
no  ||| S:2301 E:2304 ||| DT
particular  ||| S:2304 E:2315 ||| JJ
results  ||| S:2315 E:2323 ||| NNS
can  ||| S:2323 E:2327 ||| MD
be  ||| S:2327 E:2330 ||| VB
achieved ||| S:2330 E:2338 ||| VBN
,  ||| S:2338 E:2340 ||| ,
in  ||| S:2340 E:2343 ||| IN
contrast  ||| S:2343 E:2352 ||| NN
to  ||| S:2352 E:2355 ||| TO
the  ||| S:2355 E:2359 ||| DT
high-risk  ||| S:2359 E:2369 ||| JJ
groups  ||| S:2369 E:2376 ||| NNS
of  ||| S:2376 E:2379 ||| IN
PwDM  ||| S:2379 E:2384 ||| JJ
where  ||| S:2384 E:2390 ||| WRB
patient  ||| S:2390 E:2398 ||| NN
and  ||| S:2398 E:2402 ||| CC
professional  ||| S:2402 E:2415 ||| JJ
education  ||| S:2415 E:2425 ||| NN
has  ||| S:2425 E:2429 ||| VBZ
shown  ||| S:2429 E:2435 ||| VBN
significant  ||| S:2435 E:2447 ||| JJ
achievement  ||| S:2447 E:2459 ||| NN
( ||| S:2459 E:2460 ||| -LRB-
EBM-IV ||| S:2460 E:2466 ||| NNP
/ ||| S:2466 E:2467 ||| NNP
C ||| S:2467 E:2468 ||| NNP
) ||| S:2468 E:2469 ||| -RRB-
.  ||| S:2469 E:2471 ||| .
In  ||| S:2471 E:2474 ||| IN
secondary  ||| S:2474 E:2484 ||| JJ
prevention  ||| S:2484 E:2495 ||| NN
of  ||| S:2495 E:2498 ||| IN
DF ||| S:2498 E:2500 ||| NNP
,  ||| S:2500 E:2502 ||| ,
it  ||| S:2502 E:2505 ||| PRP
is  ||| S:2505 E:2508 ||| VBZ
necessary  ||| S:2508 E:2518 ||| JJ
to  ||| S:2518 E:2521 ||| TO
perform  ||| S:2521 E:2529 ||| VB
patient  ||| S:2529 E:2537 ||| NN
and  ||| S:2537 E:2541 ||| CC
professional  ||| S:2541 E:2554 ||| JJ
education  ||| S:2554 E:2564 ||| NN
how  ||| S:2564 E:2568 ||| WRB
to  ||| S:2568 E:2571 ||| TO
avoid  ||| S:2571 E:2577 ||| VB
most  ||| S:2577 E:2582 ||| JJS
of  ||| S:2582 E:2585 ||| IN
external  ||| S:2585 E:2594 ||| JJ
influences  ||| S:2594 E:2605 ||| NNS
for  ||| S:2605 E:2609 ||| IN
DE  ||| S:2609 E:2612 ||| NNP
Patient  ||| S:2612 E:2620 ||| NNP
education  ||| S:2620 E:2630 ||| NN
should  ||| S:2630 E:2637 ||| MD
include  ||| S:2637 E:2645 ||| VB
all  ||| S:2645 E:2649 ||| DT
topics  ||| S:2649 E:2656 ||| NNS
from  ||| S:2656 E:2661 ||| IN
primary  ||| S:2661 E:2669 ||| JJ
prevention ||| S:2669 E:2679 ||| NN
,  ||| S:2679 E:2681 ||| ,
danger  ||| S:2681 E:2688 ||| NN
of  ||| S:2688 E:2691 ||| IN
neural  ||| S:2691 E:2698 ||| JJ
analgesia  ||| S:2698 E:2708 ||| NNS
( ||| S:2708 E:2709 ||| -LRB-
no  ||| S:2709 E:2712 ||| DT
cooling  ||| S:2712 E:2720 ||| NN
or  ||| S:2720 E:2723 ||| CC
warming  ||| S:2723 E:2731 ||| VBG
the  ||| S:2731 E:2735 ||| DT
foot ||| S:2735 E:2739 ||| NN
) ||| S:2739 E:2740 ||| -RRB-
,  ||| S:2740 E:2742 ||| ,
careful  ||| S:2742 E:2750 ||| JJ
selection  ||| S:2750 E:2760 ||| NN
of  ||| S:2760 E:2763 ||| IN
shoes ||| S:2763 E:2768 ||| NNS
,  ||| S:2768 E:2770 ||| ,
daily  ||| S:2770 E:2776 ||| JJ
observation  ||| S:2776 E:2788 ||| NN
of  ||| S:2788 E:2791 ||| IN
foot ||| S:2791 E:2795 ||| NN
,  ||| S:2795 E:2797 ||| ,
early  ||| S:2797 E:2803 ||| RB
detection  ||| S:2803 E:2813 ||| VB
all  ||| S:2813 E:2817 ||| DT
foot  ||| S:2817 E:2822 ||| NN
changes  ||| S:2822 E:2830 ||| NNS
or  ||| S:2830 E:2833 ||| CC
small  ||| S:2833 E:2839 ||| JJ
wounds ||| S:2839 E:2845 ||| NNS
,  ||| S:2845 E:2847 ||| ,
daily  ||| S:2847 E:2853 ||| JJ
hygiene  ||| S:2853 E:2861 ||| NN
of  ||| S:2861 E:2864 ||| IN
foot  ||| S:2864 E:2869 ||| NN
skin ||| S:2869 E:2873 ||| NN
,  ||| S:2873 E:2875 ||| ,
which  ||| S:2875 E:2881 ||| WDT
has  ||| S:2881 E:2885 ||| VBZ
to  ||| S:2885 E:2888 ||| TO
be  ||| S:2888 E:2891 ||| VB
clean  ||| S:2891 E:2897 ||| JJ
and  ||| S:2897 E:2901 ||| CC
moist ||| S:2901 E:2906 ||| NN
,  ||| S:2906 E:2908 ||| ,
regular  ||| S:2908 E:2916 ||| JJ
self  ||| S:2916 E:2921 ||| NN
measurements  ||| S:2921 E:2934 ||| NNS
of  ||| S:2934 E:2937 ||| IN
skin  ||| S:2937 E:2942 ||| NN
temperature  ||| S:2942 E:2954 ||| NN
between  ||| S:2954 E:2962 ||| IN
the  ||| S:2962 E:2966 ||| DT
two  ||| S:2966 E:2970 ||| CD
feet  ||| S:2970 E:2975 ||| NNS
( ||| S:2975 E:2976 ||| -LRB-
EBM-Ib ||| S:2976 E:2982 ||| NNP
/ ||| S:2982 E:2983 ||| NNP
A ||| S:2983 E:2984 ||| NNP
) ||| S:2984 E:2985 ||| -RRB-
,  ||| S:2985 E:2987 ||| ,
prevention  ||| S:2987 E:2998 ||| NN
of  ||| S:2998 E:3001 ||| IN
self  ||| S:3001 E:3006 ||| JJ
treatment  ||| S:3006 E:3016 ||| NN
of  ||| S:3016 E:3019 ||| IN
foot  ||| S:3019 E:3024 ||| NN
deformities ||| S:3024 E:3035 ||| NN
,  ||| S:3035 E:3037 ||| ,
changing  ||| S:3037 E:3046 ||| VBG
wrong  ||| S:3046 E:3052 ||| JJ
habits  ||| S:3052 E:3059 ||| NNS
( ||| S:3059 E:3060 ||| -LRB-
walking  ||| S:3060 E:3068 ||| FW
footless ||| S:3068 E:3076 ||| FW
) ||| S:3076 E:3077 ||| -RRB-
,  ||| S:3077 E:3079 ||| ,
medical  ||| S:3079 E:3087 ||| JJ
consultation  ||| S:3087 E:3100 ||| NN
for  ||| S:3100 E:3104 ||| IN
even  ||| S:3104 E:3109 ||| RB
small  ||| S:3109 E:3115 ||| JJ
foot  ||| S:3115 E:3120 ||| NN
changes  ||| S:3120 E:3128 ||| NNS
( ||| S:3128 E:3129 ||| -LRB-
EBM-Ib ||| S:3129 E:3135 ||| NNP
/ ||| S:3135 E:3136 ||| NNP
A ||| S:3136 E:3137 ||| NNP
)  ||| S:3137 E:3139 ||| -RRB-
and  ||| S:3139 E:3143 ||| CC
consultation  ||| S:3143 E:3156 ||| NN
by  ||| S:3156 E:3159 ||| IN
multidisciplinary  ||| S:3159 E:3177 ||| JJ
team  ||| S:3177 E:3182 ||| NN
( ||| S:3182 E:3183 ||| -LRB-
EBM-IIb ||| S:3183 E:3190 ||| NNP
/ ||| S:3190 E:3191 ||| NNP
B ||| S:3191 E:3192 ||| NNP
) ||| S:3192 E:3193 ||| -RRB-
.  ||| S:3193 E:3195 ||| .
Tertiary  ||| S:3195 E:3204 ||| NNP
DF  ||| S:3204 E:3207 ||| NNP
prevention  ||| S:3207 E:3218 ||| NN
includes  ||| S:3218 E:3227 ||| VBZ
ulcer  ||| S:3227 E:3233 ||| JJ
treatment ||| S:3233 E:3242 ||| NN
,  ||| S:3242 E:3244 ||| ,
prevention  ||| S:3244 E:3255 ||| NN
of  ||| S:3255 E:3258 ||| IN
amputation  ||| S:3258 E:3269 ||| NN
and  ||| S:3269 E:3273 ||| CC
level  ||| S:3273 E:3279 ||| NN
of  ||| S:3279 E:3282 ||| IN
amputation ||| S:3282 E:3292 ||| NN
.  ||| S:3292 E:3294 ||| .
In  ||| S:3294 E:3297 ||| IN
spite  ||| S:3297 E:3303 ||| NN
of  ||| S:3303 E:3306 ||| IN
the  ||| S:3306 E:3310 ||| DT
primary  ||| S:3310 E:3318 ||| JJ
and  ||| S:3318 E:3322 ||| CC
secondary  ||| S:3322 E:3332 ||| JJ
prevention  ||| S:3332 E:3343 ||| NN
measures ||| S:3343 E:3351 ||| NNS
,  ||| S:3351 E:3353 ||| ,
DF  ||| S:3353 E:3356 ||| NNP
ulcers  ||| S:3356 E:3363 ||| NNS
develop  ||| S:3363 E:3371 ||| VBP
very  ||| S:3371 E:3376 ||| RB
often ||| S:3376 E:3381 ||| RB
.  ||| S:3381 E:3383 ||| .
Because  ||| S:3383 E:3391 ||| IN
of  ||| S:3391 E:3394 ||| IN
different  ||| S:3394 E:3404 ||| JJ
etiologic  ||| S:3404 E:3414 ||| JJ
reasons  ||| S:3414 E:3422 ||| NNS
as  ||| S:3422 E:3425 ||| IN
well  ||| S:3425 E:3430 ||| RB
as  ||| S:3430 E:3433 ||| IN
different  ||| S:3433 E:3443 ||| JJ
principles  ||| S:3443 E:3454 ||| NNS
of  ||| S:3454 E:3457 ||| IN
treatment  ||| S:3457 E:3467 ||| NN
which  ||| S:3467 E:3473 ||| WDT
are  ||| S:3473 E:3477 ||| VBP
at  ||| S:3477 E:3480 ||| IN
the  ||| S:3480 E:3484 ||| DT
same  ||| S:3484 E:3489 ||| JJ
time  ||| S:3489 E:3494 ||| NN
prevention  ||| S:3494 E:3505 ||| NN
of  ||| S:3505 E:3508 ||| IN
the  ||| S:3508 E:3512 ||| DT
level  ||| S:3512 E:3518 ||| NN
of  ||| S:3518 E:3521 ||| IN
amputation ||| S:3521 E:3531 ||| NN
,  ||| S:3531 E:3533 ||| ,
the  ||| S:3533 E:3537 ||| DT
approach  ||| S:3537 E:3546 ||| NN
to  ||| S:3546 E:3549 ||| TO
PwDF  ||| S:3549 E:3554 ||| NNP
has  ||| S:3554 E:3558 ||| VBZ
to  ||| S:3558 E:3561 ||| TO
be  ||| S:3561 E:3564 ||| VB
multidisciplinary ||| S:3564 E:3581 ||| NNS
.  ||| S:3581 E:3583 ||| .
A  ||| S:3583 E:3585 ||| DT
high  ||| S:3585 E:3590 ||| JJ
place  ||| S:3590 E:3596 ||| NN
in  ||| S:3596 E:3599 ||| IN
the  ||| S:3599 E:3603 ||| DT
treatment  ||| S:3603 E:3613 ||| NN
of  ||| S:3613 E:3616 ||| IN
DF  ||| S:3616 E:3619 ||| NNP
ulcers ||| S:3619 E:3625 ||| NNS
,  ||| S:3625 E:3627 ||| ,
especially  ||| S:3627 E:3638 ||| RB
neuropathic  ||| S:3638 E:3650 ||| JJ
ulcers ||| S:3650 E:3656 ||| NNS
,  ||| S:3656 E:3658 ||| ,
have  ||| S:3658 E:3663 ||| VBP
the  ||| S:3663 E:3667 ||| DT
off-loading  ||| S:3667 E:3679 ||| JJ
principles  ||| S:3679 E:3690 ||| NNS
( ||| S:3690 E:3691 ||| -LRB-
EBM-Ib ||| S:3691 E:3697 ||| NNP
/ ||| S:3697 E:3698 ||| NNP
A ||| S:3698 E:3699 ||| NNP
) ||| S:3699 E:3700 ||| -RRB-
,  ||| S:3700 E:3702 ||| ,
even  ||| S:3702 E:3707 ||| RB
instead  ||| S:3707 E:3715 ||| RB
of  ||| S:3715 E:3718 ||| IN
surgical  ||| S:3718 E:3727 ||| JJ
treatment  ||| S:3727 E:3737 ||| NN
( ||| S:3737 E:3738 ||| -LRB-
EBM-Ib ||| S:3738 E:3744 ||| NNP
/ ||| S:3744 E:3745 ||| NNP
A ||| S:3745 E:3746 ||| NNP
) ||| S:3746 E:3747 ||| -RRB-
.  ||| S:3747 E:3749 ||| .
Necrectomy ||| S:3749 E:3759 ||| NNP
,  ||| S:3759 E:3761 ||| ,
taking  ||| S:3761 E:3768 ||| VBG
samples  ||| S:3768 E:3776 ||| NNS
for  ||| S:3776 E:3780 ||| IN
analysis  ||| S:3780 E:3789 ||| NN
from  ||| S:3789 E:3794 ||| IN
the  ||| S:3794 E:3798 ||| DT
deep  ||| S:3798 E:3803 ||| JJ
of  ||| S:3803 E:3806 ||| IN
ulcer ||| S:3806 E:3811 ||| NN
,  ||| S:3811 E:3813 ||| ,
together  ||| S:3813 E:3822 ||| RB
with  ||| S:3822 E:3827 ||| IN
x-ray  ||| S:3827 E:3833 ||| JJ
diagnostics  ||| S:3833 E:3845 ||| NNS
( ||| S:3845 E:3846 ||| -LRB-
in  ||| S:3846 E:3849 ||| IN
particular  ||| S:3849 E:3860 ||| JJ
NMR ||| S:3860 E:3863 ||| NNP
) ||| S:3863 E:3864 ||| -RRB-
,  ||| S:3864 E:3866 ||| ,
the  ||| S:3866 E:3870 ||| DT
size  ||| S:3870 E:3875 ||| NN
of  ||| S:3875 E:3878 ||| IN
the  ||| S:3878 E:3882 ||| DT
changes  ||| S:3882 E:3890 ||| NNS
can  ||| S:3890 E:3894 ||| MD
be  ||| S:3894 E:3897 ||| VB
detected ||| S:3897 E:3905 ||| VBN
,  ||| S:3905 E:3907 ||| ,
together  ||| S:3907 E:3916 ||| RB
with  ||| S:3916 E:3921 ||| IN
appropriate  ||| S:3921 E:3933 ||| JJ
antibiotic  ||| S:3933 E:3944 ||| JJ
use  ||| S:3944 E:3948 ||| NN
and  ||| S:3948 E:3952 ||| CC
indication  ||| S:3952 E:3963 ||| NN
for  ||| S:3963 E:3967 ||| IN
major  ||| S:3967 E:3973 ||| JJ
surgical  ||| S:3973 E:3982 ||| JJ
treatment ||| S:3982 E:3991 ||| NN
.  ||| S:3991 E:3993 ||| .
The  ||| S:3993 E:3997 ||| DT
patient  ||| S:3997 E:4005 ||| NN
has  ||| S:4005 E:4009 ||| VBZ
to  ||| S:4009 E:4012 ||| TO
be  ||| S:4012 E:4015 ||| VB
instructed  ||| S:4015 E:4026 ||| VBN
to  ||| S:4026 E:4029 ||| TO
the  ||| S:4029 E:4033 ||| DT
involved  ||| S:4033 E:4042 ||| JJ
DF  ||| S:4042 E:4045 ||| NN
with  ||| S:4045 E:4050 ||| IN
off-loading  ||| S:4050 E:4062 ||| NNP
( ||| S:4062 E:4063 ||| -LRB-
EBM-IIb ||| S:4063 E:4070 ||| NNP
/ ||| S:4070 E:4071 ||| NNP
A ||| S:4071 E:4072 ||| NNP
) ||| S:4072 E:4073 ||| -RRB-
.  ||| S:4073 E:4075 ||| .
Negative  ||| S:4075 E:4084 ||| JJ
pressure  ||| S:4084 E:4093 ||| NN
wound  ||| S:4093 E:4099 ||| NN
therapy  ||| S:4099 E:4107 ||| NN
can  ||| S:4107 E:4111 ||| MD
accelerate  ||| S:4111 E:4122 ||| VB
the  ||| S:4122 E:4126 ||| DT
closure  ||| S:4126 E:4134 ||| NN
of  ||| S:4134 E:4137 ||| IN
complex  ||| S:4137 E:4145 ||| JJ
diabetic  ||| S:4145 E:4154 ||| JJ
foot  ||| S:4154 E:4159 ||| NN
wounds  ||| S:4159 E:4166 ||| NNS
( ||| S:4166 E:4167 ||| -LRB-
EBM-  ||| S:4167 E:4172 ||| NNP
Ib ||| S:4172 E:4174 ||| NNP
/ ||| S:4174 E:4175 ||| NNP
A ||| S:4175 E:4176 ||| NNP
) ||| S:4176 E:4177 ||| -RRB-
.  ||| S:4177 E:4179 ||| .
DF  ||| S:4179 E:4182 ||| NNP
local  ||| S:4182 E:4188 ||| JJ
treatment  ||| S:4188 E:4198 ||| NN
as  ||| S:4198 E:4201 ||| IN
well  ||| S:4201 E:4206 ||| RB
as  ||| S:4206 E:4209 ||| RB
ulcer  ||| S:4209 E:4215 ||| VBP
covering  ||| S:4215 E:4224 ||| VBG
for  ||| S:4224 E:4228 ||| IN
detritus  ||| S:4228 E:4237 ||| JJ
absorption  ||| S:4237 E:4248 ||| NN
has  ||| S:4248 E:4252 ||| VBZ
not  ||| S:4252 E:4256 ||| RB
been  ||| S:4256 E:4261 ||| VBN
EBM  ||| S:4261 E:4265 ||| NNP
approved ||| S:4265 E:4273 ||| VBD
,  ||| S:4273 E:4275 ||| ,
although  ||| S:4275 E:4284 ||| IN
covering  ||| S:4284 E:4293 ||| VBG
can  ||| S:4293 E:4297 ||| MD
diminish  ||| S:4297 E:4306 ||| VB
secondary  ||| S:4306 E:4316 ||| JJ
infection ||| S:4316 E:4325 ||| NN
.  ||| S:4325 E:4327 ||| .
Skin  ||| S:4327 E:4332 ||| NN
or  ||| S:4332 E:4335 ||| CC
surrogate  ||| S:4335 E:4345 ||| JJ
transplantations  ||| S:4345 E:4362 ||| NN
looks  ||| S:4362 E:4368 ||| VBZ
rationale  ||| S:4368 E:4378 ||| NN
but  ||| S:4378 E:4382 ||| CC
very  ||| S:4382 E:4387 ||| RB
expensive  ||| S:4387 E:4397 ||| JJ
in  ||| S:4397 E:4400 ||| IN
comparison  ||| S:4400 E:4411 ||| NN
to  ||| S:4411 E:4414 ||| TO
off-loading ||| S:4414 E:4425 ||| JJ
.  ||| S:4425 E:4427 ||| .
Randomized  ||| S:4427 E:4438 ||| JJ
clinical  ||| S:4438 E:4447 ||| JJ
trials  ||| S:4447 E:4454 ||| NNS
do  ||| S:4454 E:4457 ||| VBP
not  ||| S:4457 E:4461 ||| RB
prove  ||| S:4461 E:4467 ||| VB
usefulness  ||| S:4467 E:4478 ||| NN
of  ||| S:4478 E:4481 ||| IN
antibiotic  ||| S:4481 E:4492 ||| JJ
treatment  ||| S:4492 E:4502 ||| NN
or  ||| S:4502 E:4505 ||| CC
surgical  ||| S:4505 E:4514 ||| JJ
intervention  ||| S:4514 E:4527 ||| NN
in  ||| S:4527 E:4530 ||| IN
uninfected  ||| S:4530 E:4541 ||| JJ
ulcer  ||| S:4541 E:4547 ||| NNS
( ||| S:4547 E:4548 ||| -LRB-
EBM-IV ||| S:4548 E:4554 ||| NNP
/ ||| S:4554 E:4555 ||| NNP
C ||| S:4555 E:4556 ||| NNP
) ||| S:4556 E:4557 ||| -RRB-
,  ||| S:4557 E:4559 ||| ,
but  ||| S:4559 E:4563 ||| CC
the  ||| S:4563 E:4567 ||| DT
decision  ||| S:4567 E:4576 ||| NN
is  ||| S:4576 E:4579 ||| VBZ
left  ||| S:4579 E:4584 ||| VBN
to  ||| S:4584 E:4587 ||| TO
the  ||| S:4587 E:4591 ||| DT
experienced  ||| S:4591 E:4603 ||| JJ
physician ||| S:4603 E:4612 ||| NN
.  ||| S:4612 E:4614 ||| .
Evidence  ||| S:4614 E:4623 ||| NN
of  ||| S:4623 E:4626 ||| IN
osteomyelitis  ||| S:4626 E:4640 ||| VBG
together  ||| S:4640 E:4649 ||| RP
with  ||| S:4649 E:4654 ||| IN
infected  ||| S:4654 E:4663 ||| JJ
DF  ||| S:4663 E:4666 ||| NNP
ulcer  ||| S:4666 E:4672 ||| NN
changes  ||| S:4672 E:4680 ||| NNS
the  ||| S:4680 E:4684 ||| DT
prognosis  ||| S:4684 E:4694 ||| NN
of  ||| S:4694 E:4697 ||| IN
treatment ||| S:4697 E:4706 ||| NN
,  ||| S:4706 E:4708 ||| ,
increasing  ||| S:4708 E:4719 ||| VBG
the  ||| S:4719 E:4723 ||| DT
importance  ||| S:4723 E:4734 ||| NN
of  ||| S:4734 E:4737 ||| IN
antibiotic  ||| S:4737 E:4748 ||| NN
or  ||| S:4748 E:4751 ||| CC
surgical  ||| S:4751 E:4760 ||| JJ
treatment  ||| S:4760 E:4770 ||| NN
( ||| S:4770 E:4771 ||| -LRB-
EBM-IIIB ||| S:4771 E:4779 ||| NNP
/ ||| S:4779 E:4780 ||| NNP
B ||| S:4780 E:4781 ||| NNP
) ||| S:4781 E:4782 ||| -RRB-
.  ||| S:4782 E:4784 ||| .
Treatment  ||| S:4784 E:4794 ||| NN
with  ||| S:4794 E:4799 ||| IN
hyperbaric  ||| S:4799 E:4810 ||| JJ
oxygen  ||| S:4810 E:4817 ||| NN
can  ||| S:4817 E:4821 ||| MD
help  ||| S:4821 E:4826 ||| VB
in  ||| S:4826 E:4829 ||| IN
wound  ||| S:4829 E:4835 ||| JJ
healing ||| S:4835 E:4842 ||| NN
,  ||| S:4842 E:4844 ||| ,
but  ||| S:4844 E:4848 ||| CC
without  ||| S:4848 E:4856 ||| IN
any  ||| S:4856 E:4860 ||| DT
influence  ||| S:4860 E:4870 ||| NN
on  ||| S:4870 E:4873 ||| IN
revascularization  ||| S:4873 E:4891 ||| NNS
( ||| S:4891 E:4892 ||| -LRB-
EBM-Ib ||| S:4892 E:4898 ||| NNP
/ ||| S:4898 E:4899 ||| NNP
A ||| S:4899 E:4900 ||| NNP
) ||| S:4900 E:4901 ||| -RRB-
.  ||| S:4901 E:4903 ||| .
At  ||| S:4903 E:4906 ||| IN
the  ||| S:4906 E:4910 ||| DT
end ||| S:4910 E:4913 ||| NN
,  ||| S:4913 E:4915 ||| ,
the  ||| S:4915 E:4919 ||| DT
decision  ||| S:4919 E:4928 ||| NN
for  ||| S:4928 E:4932 ||| IN
the  ||| S:4932 E:4936 ||| DT
level  ||| S:4936 E:4942 ||| NN
of  ||| S:4942 E:4945 ||| IN
amputation  ||| S:4945 E:4956 ||| NN
has  ||| S:4956 E:4960 ||| VBZ
to  ||| S:4960 E:4963 ||| TO
be  ||| S:4963 E:4966 ||| VB
made ||| S:4966 E:4970 ||| VBN
.  ||| S:4970 E:4972 ||| .
Charcot  ||| S:4972 E:4980 ||| JJ
neuroarthropathy  ||| S:4980 E:4997 ||| NN
is  ||| S:4997 E:5000 ||| VBZ
still  ||| S:5000 E:5006 ||| RB
not  ||| S:5006 E:5010 ||| RB
clearly  ||| S:5010 E:5018 ||| RB
defined ||| S:5018 E:5025 ||| VBN
,  ||| S:5025 E:5027 ||| ,
so  ||| S:5027 E:5030 ||| RB
the  ||| S:5030 E:5034 ||| DT
randomized  ||| S:5034 E:5045 ||| JJ
controlled  ||| S:5045 E:5056 ||| JJ
trials  ||| S:5056 E:5063 ||| NNS
are  ||| S:5063 E:5067 ||| VBP
rare ||| S:5067 E:5071 ||| JJ
;  ||| S:5071 E:5073 ||| :
thus ||| S:5073 E:5077 ||| RB
,  ||| S:5077 E:5079 ||| ,
there  ||| S:5079 E:5085 ||| EX
are  ||| S:5085 E:5089 ||| VBP
many  ||| S:5089 E:5094 ||| JJ
new  ||| S:5094 E:5098 ||| JJ
ways  ||| S:5098 E:5103 ||| NNS
of  ||| S:5103 E:5106 ||| IN
treatment  ||| S:5106 E:5116 ||| NN
but  ||| S:5116 E:5120 ||| CC
the  ||| S:5120 E:5124 ||| DT
basics  ||| S:5124 E:5131 ||| NN
belongs  ||| S:5131 E:5139 ||| VBZ
to  ||| S:5139 E:5142 ||| TO
off-loading  ||| S:5142 E:5154 ||| JJ
in  ||| S:5154 E:5157 ||| IN
simple  ||| S:5157 E:5164 ||| JJ
changes  ||| S:5164 E:5172 ||| NNS
through  ||| S:5172 E:5180 ||| IN
surgical  ||| S:5180 E:5189 ||| JJ
treatment  ||| S:5189 E:5199 ||| NN
in  ||| S:5199 E:5202 ||| IN
more  ||| S:5202 E:5207 ||| RBR
complex  ||| S:5207 E:5215 ||| JJ
changes  ||| S:5215 E:5223 ||| NNS
( ||| S:5223 E:5224 ||| -LRB-
EBM-IV ||| S:5224 E:5230 ||| NNP
/ ||| S:5230 E:5231 ||| NNP
C ||| S:5231 E:5232 ||| NNP
) ||| S:5232 E:5233 ||| -RRB-
( ||| S:5233 E:5234 ||| -LRB-
rbn1 ||| S:5234 E:5238 ||| NNP
) ||| S:5238 E:5239 ||| -RRB-
.  ||| S:5239 E:5241 ||| .
All  ||| S:5241 E:5245 ||| DT
available  ||| S:5245 E:5255 ||| JJ
methods  ||| S:5255 E:5263 ||| NNS
for  ||| S:5263 E:5267 ||| IN
detecting  ||| S:5267 E:5277 ||| VBG
the  ||| S:5277 E:5281 ||| DT
level  ||| S:5281 E:5287 ||| NN
of  ||| S:5287 E:5290 ||| IN
vascularization ||| S:5290 E:5305 ||| NN
,  ||| S:5305 E:5307 ||| ,
angioplasties ||| S:5307 E:5320 ||| NN
,  ||| S:5320 E:5322 ||| ,
and  ||| S:5322 E:5326 ||| CC
oxymetry  ||| S:5326 E:5335 ||| NNS
have  ||| S:5335 E:5340 ||| VBP
to  ||| S:5340 E:5343 ||| TO
be  ||| S:5343 E:5346 ||| VB
used  ||| S:5346 E:5351 ||| VBN
to  ||| S:5351 E:5354 ||| TO
decide  ||| S:5354 E:5361 ||| VB
on  ||| S:5361 E:5364 ||| IN
the  ||| S:5364 E:5368 ||| DT
minimal  ||| S:5368 E:5376 ||| JJ
level  ||| S:5376 E:5382 ||| NN
of  ||| S:5382 E:5385 ||| IN
amputation ||| S:5385 E:5395 ||| NN
.  ||| S:5395 E:5397 ||| .
